Ex-drug users shun hepatitis treatment
Chinese University study finds that 80 per cent of those diagnosed with disease opt against medication that cuts risk of cirrhosis, cancer
The vast majority of former drug users found to have hepatitis C in a screening programme did not take up an offer of treatment - with many apparently unwilling to take time off work to treat the disease, a Chinese University study has revealed.
Researchers from the university's centre for liver health screened 234 former users between 2009 and 2012, of whom 130, or 56 per cent, were found to have the disease. But just one in five of those accepted treatment.
While the early symptoms of hepatitis C are relatively minor, it can, if left untreated, lead to liver cirrhosis and cancer, said Professor Vincent Wong Wai-sun, deputy director of the university's Centre for Liver Health.
The hepatitis C virus is transmitted through blood and bodily fluids and is most commonly spread through the use of shared needles for the injection of drugs. The risk to the general public is low, though it can also spread through dental procedures, tattoos and body piercings
"The problem with hepatitis C is that it's difficult to find affected people to be tested," Wong said as he released the findings yesterday. "That's why we emphasise screening of high-risk people."
Of the 130 people who tested positive, 69 returned for follow-up sessions with doctors. Of those, 38 per cent opted for treatment. By comparison, an earlier study - not confined to drug users - showed that of 300 people who sought follow-up sessions, 56 per cent opted for treatment.
Early symptoms of the disease include tiredness and loss of appetite, Wong said. But of those who are not treated, 20 per cent will develop cirrhosis within 10 years. Of those, between 1 and 4 per cent will develop cancer each year. Among patients who accept treatment, 40 to 50 per cent will be clear of the virus.
